In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake

Journal of Inorganic Biochemistry

Volumn 102, Issue 2, 2008, Pages 303-310

  Liu, Johnson J ^a   Galettis, Peter ^a   Farr, Alistair ^a   Maharaj, Lenushka ^a   Samarasinha, Hasitha ^a   McGechan, Adam C ^a   Baguley, Bruce C ^b   Bowen, Richard J ^c   Berners Price, Susan J ^c,d   McKeage, Mark J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antitumour activity; Gold(I) and silver(I) phosphines; Hepatocytes; Ovarian cancer cell lines

Indexed keywords

DEOXYGLUCOSE; GOLD; PHOSPHINE DERIVATIVE; PYRIDYL PHOSPHINE; SILVER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOPHILICITY; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; OVARY CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; HEPATOCYTES; HUMANS; MALE; ORGANOGOLD COMPOUNDS; ORGANOMETALLIC COMPOUNDS; PHOSPHINES; RATS; RATS, WISTAR; SILVER;

RATTUS;

EID: 38149056658     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2007.09.003     Document Type: Article

References (32)

1. Kelland L.R., Mistry P., Abel G., Loh S.Y., O'Neill C.F., Murrer B.A., and Harrap K.R. Cancer Res. 52 (1992) 3857-3864
2. Mistry P., Kelland L.R., Abel G., Sidhar S., and Harrap K.R. Br. J. Cancer 64 (1991) 215-220
3. Marzano C., Gandin V., Folda A., Scutari G., Bindoli A., and Rigobello M.P. Free Radical Bio. Med. 42 (2007) 872-881
4. Berners-Price S.J., Mirabelli C.K., Johnson R.K., Mattern M.R., McCabe F.L., Faucette L.F., Sung C.M., Mong S.M., Sadler P.J., and Crooke S.T. Cancer Res. 46 (1986) 5486-5493
5. McKeage M.J., Maharaj L., and Berners-Price S.J. Coord. Chem. Rev. 232 (2002) 127-135
6. Hoke G.D., McCabe F.L., Faucette L.F., Bartus J.O., Sung C.M., Jensen B.D., Heys J.R., Rush G.F., Alberts D.W., Johnson R.K., and Mirabelli C.K. Mol. Pharmacol. 39 (1990) 90-97
7. Hoke G.D., Rush G.F., Bossard G.E., McArdle J.V., Jensen B.D., and Mirabelli C.K. J. Biol. Chem. 263 (1988) 11203-11210
8. Smith P.F., Hoke G.D., Alberts D.W., Bugelski P.J., Lupo S., Mirabelli C.K., and Rush G.F. J. Pharmacol. Exp. Ther. 249 (1989) 944-950
9. Erdogan E., Lamark T., Stallings-Mann M., Jamieson L., Pellechia M., Thompson E.A., Johansen T., and Fields A.P. J. Biol. Chem. 281 (2006) 28450-28459
10. Stallings-Mann M., Jamieson L., Regala R.P., Weems C., Murray N.R., and Fields A.P. Cancer Res. 66 (2006) 1767-1774
11. Rush G.F., Alberts D.W., Meunier P., Leffler K., and Smith P.F. Toxicologist 7 (1987) 59
12. Berners-Price S.J., and Sadler P.J. Struct. Bond. (Berlin) 70 (1988) 27-102
13. Berners-Price S.J., Girard G.R., Hill D.T., Sutton B.M., Jarrett P.S., Faucette L.F., Johnson R.K., Mirabelli C.K., and Sadler P.J. J. Med. Chem. 33 (1990) 1386-1392
14. Bowen R.J., Garner A.C., Berners-Price S.J., Jenkins I.D., and Sue R.E. J. Organomet. Chem. 554 (1998) 181-184
15. Berners-Price S.J., Bowen R.J., Harvey P.J., Healy P.C., and Koutsantonis G.A. J. Chem. Soc. Dalton Trans. 11 (1998) 1743-1750
16. Berners-Price S.J., Bowen R.J., Hambley T.W., and Healy P.C. J. Chem. Soc. Dalton Trans. 8 (1999) 1337-1346
17. Berners-Price S.J., Bowen R.J., Galettis P., Healy P.C., and McKeage M.J. Coord. Chem. Rev. 186 (1999) 823-836
18. Berners-Price S.J., and Sadler P.J. Inorg. Chem. 25 (1986) 3822-3827
19. McKeage M.J., Berners-Price S.J., Galettis P., Bowen R.J., Brouwer W., Ding L., Zhuang L., and Baguley B.C. Cancer Chemother. Pharmacol. 46 (2000) 343-350
20. Berry M.N., and Friend D.S. J. Cell Biol. 43 (1969) 506-520
21. Jauregui H.O., Hayner N.T., Driscoll J.L., Williams-Holland R., Lipsky M.H., and Galletti P.M. In Vitro-J Tissue Cu1t. Assoc. 17 (1981) 1100-1110
22. Judah J.D. Biochem. J. 49 (1951) 271-285
23. Johnson L.V., Walsh M.L., and Chen L.B. Proc. Natl. Acad. Sci. USA 77 (1980) 990-994
24. Modica-Napolitano J.S., Koya K., Weisberg E., Brunelli B.T., Li Y., and Chen L.B. Cancer Res. 56 (1996) 544-550
25. Steen H., Maring J.G., and Meijer D.K.F. Biochem. Pharmacol. 45 (1993) 809-818
26. Berners-Price S.J., Jarrett P.S., and Sadler P.J. Inorg. Chem. 26 (1987) 3074-3077
27. R.J. Bowen, Ph.D. thesis, Griffith University, Brisbane, Australia, 2000.
28. Berners-Price S.J., and Sadler P.J. Coord. Chem. Rev. 151 (1996) 1-40
29. Barnard P.J., and Berners-Price S.J. Coord. Chem. Rev. 251 (2007) 1889-1902
30. Mirabelli C.K., Hill D.T., Faucette L.F., McCabe F.L., Girard G.R., Bryan D.B., Sutton B.M., O'Leary Bartus J., Crooke S.T., and Johnson R.K. J. Med. Chem. 30 (1987) 2181-2190
31. Rackman O., Nichols S.J., Leedman P.J., Berners-Price S.J., and Filipovska A. Biochem. Pharmacol. 74 (2007) 992-1002
32. S.J. Berners-Price, R.K. Johnson, C.K. Mirabelli, P.J. Sadler, US Patent, 5037812 (August 6, 1991).